Universal outcomes as a common metric across multiple diseases in elders

普遍结果作为老年人多种疾病的通用指标

基本信息

  • 批准号:
    7914152
  • 负责人:
  • 金额:
    $ 16.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-15 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Multiple morbidity complicates clinical decision-making and health policy. The prevention, diagnosis, and treatment of multiple diseases are burdensome, expensive, and potentially contradictory or harmful. Treating one disease may make other(s) worse. Furthermore, individuals with multiple diseases have varying health outcome priorities. Resolving these challenges and conflicts is difficult without a common metric to compare, contrast, and/or combine across diseases. The goal of this line of investigation, beginning with this exploratory study, will be to provide evidence supporting universal health outcomes as the unifying focus and common metric across chronic diseases. The purpose of this exploratory study is to determine whether disease-specific outcomes represent intermediates outcomes that mediate the effect of individual diseases on universal health outcomes. The primary aim is to determine, for individual chronic diseases, whether and to what extent disease-specific outcomes represent intermediate outcomes between the disease and one or more universal health outcomes. We will test the hypothesis that >50% of the effect of each of 4 diseases on one or more universal outcomes is mediated through the disease-specific outcomes. The secondary aim is to determine, for the combination of coexisting diseases, whether and to what extent disease-specific outcomes mediate the effect of the combination of coexisting diseases on universal health outcomes (this aim extends the primary aim by considering all 4 diseases together). We will address these aims in two longitudinal cohorts of older adults, the Women's Health and Aging Study I and ll and Cardiovascular Health Study. The chronic diseases include: heart failure, dementia, chronic lung disease, and arthritis. The universal outcome domains include: 1) Basic, instrumental, and social- productive activities of daily living; 2) psychological functioning; 3) cognitive functioning; 4) symptom and impairment burden; and 5) survival /death. Finding that disease-specific outcomes map unto a universal set of health outcomes would support universal health outcomes as a common metric across diseases. If verified in future definitive studies, results of this line of investigation could ultimately inform clinical decision-making, research, and health policy. PUBLIC HEALTH RELEVANCE: The prevention, diagnosis, and treatment of multiple diseases are burdensome, expensive, and potentially contradictory or harmful. Resolving these challenges and conflicts is difficult without a common metric to compare, contrast, and/or combine across diseases. If disease-specific outcomes map unto a universal set of health outcomes, then these universal health outcomes could serve as common metrics across diseases that could inform clinical decision-making, research, quality assurance, and health policy.
描述(由申请人提供):多重发病率使临床决策和健康政策复杂化。多种疾病的预防,诊断和治疗是繁重的,昂贵的,并且可能矛盾或有害。治疗一种疾病可能会使另一种疾病恶化。此外,患有多种疾病的人的健康结果重点不同。如果没有通用指标,就很难解决这些挑战和冲突,可以比较,对比和/或跨疾病。从这项探索性研究开始,这种调查的目的是提供支持普遍健康结果的证据,作为统一的重点和跨慢性疾病的普通指标。这项探索性研究的目的是确定疾病特异性结果是否代表了中间的结果,可以介导个人疾病对普遍健康结果的影响。主要目的是确定个体慢性疾病,无论疾病特定的结果是否代表疾病与一种或多种普遍健康结果之间的中间结果。我们将测试以下假设:4种疾病中每种疾病对一种或多种普遍结果的影响的50%是通过疾病特异性结果介导的。第二个目的是确定共存疾病的结合,是否以及在何种程度上介导了疾病特异性的结果介导共存疾病对普遍健康结果的影响(此目的通过考虑所有4种疾病一起考虑了主要目的)。我们将在两个老年人的纵向人群中解决这些目标,即女性健康和衰老研究I和LL和心血管健康研究。慢性疾病包括:心力衰竭,痴呆,慢性肺部疾病和关节炎。普遍的结果领域包括:1)日常生活的基本,工具和社会生产活动; 2)心理功能; 3)认知功能; 4)症状和障碍负担; 5)生存 /死亡。发现特定疾病的结果映射到一系列普遍的健康结果将支持普遍的健康结果,这是跨疾病的常见指标。如果在未来的确定研究中得到验证,则此调查的结果最终可能会为临床决策,研究和卫生政策提供依据。公共卫生相关性:多种疾病的预防,诊断和治疗是繁重的,昂贵的且可能矛盾或有害的。如果没有通用指标,就很难解决这些挑战和冲突,可以比较,对比和/或跨疾病。如果特定于疾病的结果映射到一系列普遍的健康状况,那么这些普遍的健康结果可以作为跨疾病的常见指标,这些指标可以为临床决策,研究,质量保证和健康政策提供依据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY E TINETTI其他文献

MARY E TINETTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY E TINETTI', 18)}}的其他基金

Effect of treating one disease on other diseases and health outcomes in elders
治疗一种疾病对其他疾病和老年人健康结果的影响
  • 批准号:
    8021324
  • 财政年份:
    2011
  • 资助金额:
    $ 16.79万
  • 项目类别:
Effect of treating one disease on other diseases and health outcomes in elders
治疗一种疾病对其他疾病和老年人健康结果的影响
  • 批准号:
    8322607
  • 财政年份:
    2011
  • 资助金额:
    $ 16.79万
  • 项目类别:
Therapeutic competition among diseases in elders: Frequency and outcomes
老年人疾病之间的治疗竞争:频率和结果
  • 批准号:
    8335470
  • 财政年份:
    2011
  • 资助金额:
    $ 16.79万
  • 项目类别:
Therapeutic competition among diseases in elders: Frequency and outcomes
老年人疾病之间的治疗竞争:频率和结果
  • 批准号:
    7988652
  • 财政年份:
    2011
  • 资助金额:
    $ 16.79万
  • 项目类别:
B-Blocker effect on a range of health outcomes in older adults with CAD and COPD
B 受体阻滞剂对患有 CAD 和 COPD 的老年人的一系列健康结果的影响
  • 批准号:
    8013756
  • 财政年份:
    2010
  • 资助金额:
    $ 16.79万
  • 项目类别:
LEADERSHIP/ ADMINISTRATIVE CORE
领导/行政核心
  • 批准号:
    7424112
  • 财政年份:
    2008
  • 资助金额:
    $ 16.79万
  • 项目类别:
Death as a multifactorial cumulative health event in older adults
死亡是老年人的多因素累积健康事件
  • 批准号:
    7575112
  • 财政年份:
    2008
  • 资助金额:
    $ 16.79万
  • 项目类别:
Death as a multifactorial cumulative health event in older adults
死亡是老年人的多因素累积健康事件
  • 批准号:
    7369995
  • 财政年份:
    2008
  • 资助金额:
    $ 16.79万
  • 项目类别:
Need for tailored clinical trials: hypertension and fall risk
需要量身定制的临床试验:高血压和跌倒风险
  • 批准号:
    7009156
  • 财政年份:
    2005
  • 资助金额:
    $ 16.79万
  • 项目类别:
Need for tailored clinical trials: hypertension and fall risk
需要量身定制的临床试验:高血压和跌倒风险
  • 批准号:
    7140603
  • 财政年份:
    2005
  • 资助金额:
    $ 16.79万
  • 项目类别:

相似国自然基金

城市夜间日常生活区的演进过程、活力机制与更新治理路径研究
  • 批准号:
    52378053
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
川江流域山地旧城滨水区日常生活空间与地形关系演进及其当代传承研究:以重庆为例(1891-2004)
  • 批准号:
    52308006
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
中国城市-乡村生活方式移民的乡村意象与日常生活研究
  • 批准号:
    42201250
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
融合媒介环境学视角的日常生活空间体验研究
  • 批准号:
    42171221
  • 批准年份:
    2021
  • 资助金额:
    47 万元
  • 项目类别:
    面上项目

相似海外基金

Environmental Moderation of Genetic Influences on Dementia Risk in Mexican Older Adults
环境调节基因对墨西哥老年人痴呆风险的影响
  • 批准号:
    10607226
  • 财政年份:
    2023
  • 资助金额:
    $ 16.79万
  • 项目类别:
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes
类风湿性关节炎相关的肺实质疾病:临床和分子表型
  • 批准号:
    10610460
  • 财政年份:
    2022
  • 资助金额:
    $ 16.79万
  • 项目类别:
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes
类风湿性关节炎相关的肺实质疾病:临床和分子表型
  • 批准号:
    10446060
  • 财政年份:
    2022
  • 资助金额:
    $ 16.79万
  • 项目类别:
Evaluation of a Novel Passive Back-Support Exosuit (BSE) for Back Injury Prevention in Older Adults
新型被动式背部支撑外装(BSE)预防老年人背部损伤的评估
  • 批准号:
    10460916
  • 财政年份:
    2021
  • 资助金额:
    $ 16.79万
  • 项目类别:
Evaluation of a Novel Passive Back-Support Exosuit (BSE) for Back Injury Prevention in Older Adults
新型被动式背部支撑外装(BSE)预防老年人背部损伤的评估
  • 批准号:
    10154322
  • 财政年份:
    2021
  • 资助金额:
    $ 16.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了